Skip to content
Screener

Sutro Biopharma STRO Income Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
$9.1M-6.1%$9.84M-84.6%$14.52M-16.5%$11.65M-21.4%$9.69M+13.8%
$23.5M-41.0%$31.7M-17.3%$36.55M-29.2%$36.64M-48.4%$39.85M-35.8%
$7.54M-13.8%$7.83M-24.3%$7.58M-42.9%$8.66M-4.1%$8.74M-39.0%
$31.05M-46.6%$39.73M-40.8%$44.18M-48.6%$49.7M-37.9%$58.15M-23.9%
-$21.96M+54.7%-$29.89M-794%-$29.66M+56.7%-$38.05M+41.7%-$48.46M+28.7%
-241.3%+259pp-303.8%-299pp-204.2%+190pp-326.7%+114pp-499.9%+297pp
-$31.49M+44.6%-$38.53M-235%-$38.5M+49.3%-$46.84M+33.2%-$56.86M-16.5%
$0—$1K+106%-$15K-314%-$82K-103%$0—
-$31.49M+44.6%-$38.53M-235%-$38.48M+49.3%-$46.76M+35.4%-$56.86M-16.5%
-346.1%+240pp-391.6%-374pp-265%+172pp-401.5%+87.7pp-586.6%-14.0pp
-$1.90-184%-$2.33-72.6%-$2.94+67.6%-$20.78+24.0%-$0.67-13.6%
-$20.71M+55.5%-$28.63M-1,881%-$28.38M+57.4%-$36.43M+42.5%-$46.56M+29.6%
-227.7%+253pp-290.9%-289pp-195.4%+187pp-312.7%+115pp-480.3%+296pp
-$21.96M+54.7%-$29.89M-794%-$29.66M+56.7%-$38.05M+41.7%-$48.46M+28.7%

FAQ

What is Sutro Biopharma's revenue?
Sutro Biopharma (STRO) generated $45.1M in revenue over the trailing twelve months, down 57.3% year over year.
Is Sutro Biopharma profitable?
Sutro Biopharma is not currently profitable: it reported a net loss of $155.3M over the trailing twelve months, a -344.2% net margin.
What is Sutro Biopharma's earnings per share?
Sutro Biopharma's diluted EPS over the trailing twelve months is $-27.95.
Where does Sutro Biopharma's income statement data come from?
Every line is extracted from Sutro Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.